Request for Information on the Development of the FY 2019 Trans-NIH Plan for HIV-Related Research

Notice Number: NOT-OD-17-053

Key Dates
Release Date: April 11, 2017
Response Date: May 15, 2017

Related Announcements
NOT-OD-15-137

Issued by
National Institutes of Health (NIH)
Office of AIDS Research (OAR)

Purpose

Through this Request for Information (RFI), the Office of AIDS Research (OAR) in the Division of Program Coordination, Planning, and Strategic Initiatives, National Institutes of Health (NIH) invites feedback from investigators in academia, industry, health care professionals, patient advocates and health advocacy organizations, scientific or professional organizations, federal agencies, community, and other interested constituents on the development of the fiscal year 2019 Trans-NIH Plan for HIV-Related Research.  This plan is designed to identify and articulate future directions to maximize the NIH’s investments in HIV/AIDS research.

Background

OAR oversees and coordinates the conduct and support of all HIV/AIDS research activities across the NIH Institutes and Centers (ICs).  The NIH-sponsored HIV/AIDS research program includes both extramural and intramural research, buildings and facilities, research training, program evaluation, and supports a comprehensive portfolio of research representing a broad range of basic, clinical, behavioral, social science, and translational research on HIV/AIDS and its associated coinfections and comorbidities. 

OAR plans and coordinates research through the development of an annual Trans-NIH Plan for HIV-Related Research that articulates the overarching HIV/AIDS research priorities and serves as the framework for developing the trans-NIH HIV/AIDS research budget.  This Plan provides information about the NIH’s HIV/AIDS research priorities to the scientific community, Congress, community stakeholders, HIV-affected communities, and the broad public at large.  The fiscal year 2018 Trans-NIH Plan for HIV-Related Research was recently distributed on the OAR website: https://www.oar.nih.gov/strategic_plan/plan_18.asp.

New overarching priorities for HIV/AIDS research were defined in the NIH Director’s Statement of August 12, 2015 (https://grants.nih.gov/?grants/?guide/?notice-files/?NOT-OD-15-137.html).

High Priority topics of research for support include:

1) Reducing the incidence of HIV/AIDS
2) Developing the next generation of HIV therapies
3) Identifying strategies towards a cure
4) Improving the prevention and treatment of HIV-associated comorbidities, coinfections, and     complications
5) Cross-cutting basic research, behavioral and social science research, health disparities, and training
Information Requested 

Submitting a response

This Office of AIDS Research RFI is open for public comment from 03/29/2017 to 05/15/2017.  Comments must be received by May 15, 2017 to ensure consideration.  After the public comment period has closed, the comments received will be considered in a timely manner by the Office of AIDS Research in the Division of Program Coordination, Planning, and Strategic Initiatives.

View the information requested and respond electronically at http://grants.nih.gov/grants/rfi/rfi.cfm?ID=63 or, if needed, by mail to Paul Gaist, Ph.D., M.P.H. Office of AIDS Research, National Institutes of Health, Room 2E40, 5601 Fishers Lane, Rockville, Maryland 20852.

Responses to this RFI Notice are voluntary. The submitted information will be reviewed by NIH staff and may be made available to the public.  Submitted information will not be considered confidential.  This request is for information and planning purposes and should not be construed as a solicitation or as an obligation of the federal government or the NIH.  No awards will be made based on responses to this Request for Information.  The information submitted will be analyzed and may be used in reports or presentations.  Those who respond are advised that the NIH is under no obligation to acknowledge receipt of your comments or provide comments on your submission.  No proprietary, classified, confidential and/or sensitive information should be included in your response.  The NIH and the government reserve the right to use any non-proprietary technical information in any future solicitation(s).

Inquiries

Please direct all inquiries to:

Paul Gaist, Ph.D., M.P.H.
Office of AIDS Research
Email: ODOARRFI19@nih.gov